11 May 2024 -- Six in every 10 tuberculosis-affected households in India experience “catastrophic” costs, a study has suggested, indicating that the central TB control programme’s milestone to eliminate the infection’s economic distress to households by 2020 remains unachieved.

Patients’ rights groups have accused the Union health ministry of denying shortages of key medicines for drug-resistant tuberculosis (TB) even though they say the ministry’s own figures of drug inventories indicate why patients are facing shortages.

New Delhi, Sept. 21: A drug routinely prescribed for tuberculosis could possibly make people vulnerable to repeat TB attacks by harming a key protective arm of the immune system, a study in India on laboratory mice suggests.